# FDA Inspection 661717 - Oregon Health & Science University - May 12, 2010

Source: https://www.keypedia.com/records/fda_inspections/oregon-health-science-university/ee0372f3-ca17-45ff-8759-9fa48072da40
Source feed: FDA_Inspections

> FDA Inspection 661717 for Oregon Health & Science University on May 12, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 661717
- Company Name: Oregon Health & Science University
- Inspection Date: 2010-05-12
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 884662 - 2014-06-25](https://www.keypedia.com/records/fda_inspections/oregon-health-science-university/ca86ce37-8d01-477d-85da-9a949800275d)
- [FDA Inspection 697715 - 2010-11-15](https://www.keypedia.com/records/fda_inspections/oregon-health-science-university/40d9b676-8e2c-4cdb-a002-9c1f7cceaeae)
- [FDA Inspection 562116 - 2009-01-28](https://www.keypedia.com/records/fda_inspections/oregon-health-science-university/1e0eef85-8de0-42ff-8c82-23507ba3c7f7)

Company: https://www.keypedia.com/companies/oregon-health-science-university/1c503537-51fa-4bc0-90a7-fdf9041ce4ed

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
